Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:


Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Technetium tc-99m medronate - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for technetium tc-99m medronate and what is the scope of freedom to operate?

Technetium tc-99m medronate is the generic ingredient in seven branded drugs marketed by Jubilant Draximage, Ge Healthcare, Pharmalucence, and Cardinal Health 414, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for technetium tc-99m medronate. One supplier is listed for this compound.

Summary for technetium tc-99m medronate
Recent Clinical Trials for technetium tc-99m medronate

Identify potential brand extensions & 505(b)(2) entrants

University of UtahPhase 2
Winnipeg Regional Health AuthorityPhase 3
University of ManitobaPhase 3

See all technetium tc-99m medronate clinical trials

US Patents and Regulatory Information for technetium tc-99m medronate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare AMERSCAN MDP KIT technetium tc-99m medronate kit INJECTABLE;INJECTION 018335-001 Aug 5, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmalucence CIS-MDP technetium tc-99m medronate kit INJECTABLE;INJECTION 018124-001 Approved Prior to Jan 1, 1982 RX No No   Start Trial   Start Trial   Start Trial
Jubilant Draximage DRAXIMAGE MDP-10 technetium tc-99m medronate INJECTABLE;INJECTION 018035-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.